Skip to main content
. Author manuscript; available in PMC: 2021 Oct 6.
Published in final edited form as: Mol Pharm. 2017 Feb 3;14(5):1384–1394. doi: 10.1021/acs.molpharmaceut.6b01005

Table 2.

Copolymerization of HPMA with MA-GFLG–GEMa,b,c

[CTA]/[I] initiator solvent temp (°C) time (h) Mw (kDa) PDI yield (%) drug% (wt)
G-1 2.5 V65 DMSO/H+ 50 24 73.6 1.22 43 10.9
G-2 1.25 V65 DMSO/H+ 50 24 97.6 1.20 65 11.4
G-3 2.5 VA044 DMSO/H2O 1:1 (v/v) 70 2 81.2 1.25 54 12.2
G-4 1.25 VA044 DMSO/H2O 3:1 (v/v) 40 48 148.3 1.27 76 12.6
G-5 1.25 VA044 DMSO/H2O 3:1 (v/v) 40 24 61.5 1.15 40 12.3
a

200 mg scale, 134 mg HPMA/66 mg MA-GFLG–GEM; GEM 9.1% molar ratio in feed.

b

Monomer concentration 16.6% (wt).

c

[M]/[CTA] = 1030.